Suchergebnisse - "Azizad, Masoud"

PubPharm (10)

1

Bebtelovimab, alone or together with bamlanivimab and etesevimab, as a broadly neutralizing monoclonal antibody treatment for mild to moderate, ambulatory COVID-19

enthalten in: bioRxiv.org | 2023

von Dougan, M. | Azizad, M. | Chen, P. | +19

2

Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants : An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial

enthalten in: Infectious diseases and therapy | 2023

von Upadhyaya, H. | Chien, J. | Long, A. | +52

3

Molnupiravir, an Oral Antiviral Treatment for COVID-19

enthalten in: bioRxiv.org | 2022

von Fischer, W. | Eron, J. | Holman, W. | +15

4

A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Dougan, M. | Azizad, M. | Mocherla, B. | +31

5

Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19 : A Randomized Clinical Trial

enthalten in: JAMA | 2022

von Gupta, A. | Gonzalez-Rojas, Y. | Juarez, E. | +65

6

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

enthalten in: Science translational medicine | 2022

von Fischer, W. | Eron, J. | Holman, W. | +16

UpdateOf: medRxiv. 2021 Jun 17;:. - PMID 34159342

7

Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19

enthalten in: The New England journal of medicine | 2021

von Dougan, M. | Nirula, A. | Azizad, M. | +131

8

Molnupiravir, an Oral Antiviral Treatment for COVID-19

enthalten in: medRxiv : the preprint server for health sciences | 2021

von Fischer, W. | Eron, J. | Holman, W. | +15

UpdateIn: Sci Transl Med. 2022 Jan 19;14(628):eabl7430. - PMID 34941423

9

Hemodynamic Effects of Sacubitril-Valsartan Versus Enalapril in Patients With Heart Failure in the EVALUATE-HF Study : Effect Modification by Left Ventricular Ejection Fraction and Sex

enthalten in: Circulation. Heart failure | 2021

von Mitchell, G. | Solomon, S. | Shah, A. | +91

10

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

enthalten in: The New England journal of medicine | 2021

von Chen, P. | Nirula, A. | Heller, B. | +120

CommentIn: N Engl J Med. 2020 Dec 30;384(2):. - PMID 33378610

1
[1]